The Summer issue of Drug Discovery World (DDW) is out now! The DDW Summer issue is out now and looks at where the global biotech hubs are for drug discovery and development, asks how 3D genomics can accelerate personalised medicine, and looks at the technological advances in mass spectrometry. It also includes an exclusive global cancer research guide examining the innovation happening in this sector. Other features in the Summer issue include: - How AI can advance the hit-to-lead process - GSK’s efforts in the autoimmune sector - Improving viral vector safety for cell & gene therapy Read the digital version here: https://lnkd.in/eEiBFnsz #DrugDiscovery #DrugDevelopment #LifeSciences
Drug Discovery World
Book and Periodical Publishing
The Global Business Review of Drug Discovery and Development
About us
Welcome to our LinkedIn page. This is where we will share original content from the DDW team and industry experts, as well as daily news and other company updates. Published for over 20 years, DDW is the only truly global business review of all aspects of drug discovery and development and has firmly established itself as a highly respected and ‘must read’ journal within the discovery and development arena. DDW is renowned for voicing the opinions of some of the Industry’s leading luminaries and has become a recognised ‘platform’ for ‘Industry Gurus’ to discuss and encourage debate on some of the more challenging issues surrounding the technological, strategic and business facets of the pharma and biopharmaceutical industry. DDW has always adhered to the maxim….’Turning Science into Business’. DDW examines the advances in new science and technology with a view to the commercial implications of implementing those advances and whether they can truly bring benefits to the drug discovery and development process with the goal of reducing costs and attrition rates whilst ultimately, bringing new and effective therapeutics to the market faster. DDW is distinguishable in that it reaches out to a global audience at both bench and boardroom level allowing them to understand the new technologies and strategies and the impact they can have on their particular segments of the business. Scientist and CEO alike can profit from the uncomplicated style of the editorial and, furthermore, gain a wealth of information on a diverse range of life science topics. In our articles, we challenge the industry to look at new ways of overcoming discovery bottlenecks, embrace new technologies, form relationships with discovery partners and build next generation technology platforms.
- Website
-
https://www.ddw-online.com/
External link for Drug Discovery World
- Industry
- Book and Periodical Publishing
- Company size
- 2-10 employees
- Headquarters
- London
- Type
- Privately Held
- Founded
- 2000
- Specialties
- Drug Discovery, Pharmaceuticals, Publishing, Biotechnology, and Biopharmaceutical
Locations
-
Primary
Get directions
London, GB
Employees at Drug Discovery World
Updates
-
Evotec and Pfizer collaborate on metabolic and infectious diseases https://lnkd.in/e2sxRTw3 #InfectiousDiseases #DrugDiscovery #Collaboration
-
-
On Friday 5 July, the United Kingdom saw a change in government to the Labour Party after 14 years of Conservative Party leadership. Following the news that the UK economy exceeded expectations again in May, DDW’s Megan Thomas explores how this political change will influence the global life science sector. https://lnkd.in/dSfCgERs #UKelection #lifesciences #drugdiscovery
-
The latest episode of the DDW Highlights podcast, narrated by Megan Thomas, is now available. Clinical trial news has caught our attention this week. Despite the revelation from Phesi that a third of clinical trials fail at Phase II, DDW has reported positive human trial updates on therapeutics for myasthenia gravis, non-small cell lung cancer, Marburg virus, and Parkinson’s disease. https://lnkd.in/e-pnXacG #clinicaltrials #drugdiscovery #podcast
New DDW Highlights podcast: 15 July 2024 - Drug Discovery World (DDW)
https://www.ddw-online.com
-
Closed Loop Medicine joins NVIDIA Inception programme https://lnkd.in/eg-ZSk7P #DrugDiscovery #StartUps #Biotechnology
-
-
New survey findings have revealed that 77% of R&D professionals are not using in vitro cell-based alternatives to animal testing, and only 23% describe themselves as ‘very familiar’ with any kind of animal model alternative. Read more: https://lnkd.in/erVNvnBB Pistoia Alliance #drugdiscovery #animalmodels #nonanimalmodels
77% of researchers not using alternatives to animal testing - Drug Discovery World (DDW)
https://www.ddw-online.com
-
Accelerating drug discovery: The impact of ultra-fast screening https://lnkd.in/e2VAx3PX #DrugDiscovery #Imaging #Screening
-
-
In June 2023, a patient at Universitätsklinikum Erlangen in Germany became the first child with lupus to receive CAR-T therapy. The treatment was the last resort to slow down systemic lupus erythematosus (SLE), which was attacking the patient’s body and seriously affected her ability to lead a normal life. Read more: https://lnkd.in/e5MeqyqH #CART #celltherapy #autoimmunedisease #advancedtherapies
Successful off-label use of CAR-T therapy in a child with lupus - Drug Discovery World (DDW)
https://www.ddw-online.com
-
US and UK fast track designations for Parkinson’s gene therapy https://lnkd.in/eJ-TUQnE #GeneTherapy #Parkinsons #DrugDiscovery Asklepios BioPharmaceutical, Inc. (AskBio)
-
-
Increase in diabetes research fuelled by GLP-1s like Ozempic https://lnkd.in/eRd2HWu2 #Ozempic #ClinicalTrials #Diabetes
-